FindTrial
Sign In

A randomized controlled trial of effect of endoscopic submucosal dissection (ESD) combined with radiotherapy, ESD alone and radiotherapy alone for intramucosal esophageal cancer

A randomized controlled trial of effect of endoscopic submucosal dissection (ESD) combined with radiotherapy, ESD alone and radiotherapy alone for intramucosal esophageal cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15006192
Enrollment
Unknown
Registered
2014-11-16
Start date
2014-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

ESD and radiotherapy:ESD and radiotherapy of 50.4Gy/28F (5-year follow-up)
ESD:ESD (5-year follow-up)

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Endoscopic and pathological confirmed esophageal mucosal squamous cell carcinoma; 2. Contrast enhanced chest CT and endoscopic ultrasound examination find no enlarged lymph nodes.

Exclusion criteria

Exclusion criteria: 1. Esophageal adenocarcinoma; 2. Incomplete resection or postoperative pathology confirmed not intramucosal carcinoma; 3. Patients undergo additional surgical operation; 4. The perinatal period and lactation; 5. Suffered from malignant tumor in the past; 6. Severe cardiopulmonary disease or liver and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
The recurrence rate;The survival rate;—

Secondary

MeasureTime frame
The occurrence rate of complications;—

Contacts

Public ContactHu Bing
hxhb2015@126.com+86 18980601278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026